Clinical Trials Sponsored by Lundbech Foundation

Total 16113 results

H. Lundbeck A/S

Active, not recruiting

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

Migraine

Japan
H. Lundbeck A/S

Terminated

A Study to Evaluate Lu AF90103 in Healthy Men

Healthy

Netherlands
H. Lundbeck A/S

Terminated

Vortioxetine to Prevent Return of Symptoms in Children With Depression

Depression

United States, Mexico, Russian Federation, Colombia, Latvia, Poland, Ukraine
H. Lundbeck A/S

Active, not recruiting

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Multiple Sclerosis

United States, Germany
H. Lundbeck A/S

Completed

Eptinezumab in Adults With Migraine and Medication Overuse Headache (Sunlight)

Migraine | Medication Overuse Headache

Spain, China, Korea, Republic of, Taiwan, Georgia
H. Lundbeck A/S

Completed

A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen

Allergic Rhinitis

United Kingdom
H. Lundbeck A/S

Completed

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

Healthy Participants

United Kingdom
H. Lundbeck A/S

Completed

A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants

Healthy Young Men

Sweden
H. Lundbeck A/S

Completed

Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

Major Depressive Disorder

India
H. Lundbeck A/S

Completed

Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression (VIVRE)

Major Depressive Disorder

Spain, Czechia, Slovakia, Estonia, Sweden, Argentina, Belgium, Bulgaria, Latvia, Mexico, Russian Federation, Ukraine
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom
H. Lundbeck A/S

Completed

Real-life Effectiveness of Vortioxetine in Depression (RELIEVE)

Major Depressive Disorder

United States, Canada, France, Italy
H. Lundbeck A/S

Completed

Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men

Healthy

United States
H. Lundbeck A/S

Completed

A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain

Healthy

United Kingdom
H. Lundbeck A/S

Terminated

Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)

Healthy | Parkinson Disease

Sweden
H. Lundbeck A/S

Terminated

Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms

Schizophrenia

Bulgaria, Estonia, Hungary, Latvia, Ukraine, Germany, Poland
H. Lundbeck A/S

Completed

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

Healthy

France
H. Lundbeck A/S

Completed

A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Study With Vortioxetine on Emotional Functioning in Patients With Depression (COMPLETE)

Major Depressive Disorder

France, Italy, Lithuania, Spain
H. Lundbeck A/S

Completed

A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects

Parkinson Disease

Sweden
H. Lundbeck A/S

Completed

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia (DayBreak)

Schizophrenia

Estonia, Mexico, Poland, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Finland, Romania, Russian Federation, Slovakia, Spain
H. Lundbeck A/S

Terminated

A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)

Alzheimer's Disease

Finland, Sweden
H. Lundbeck A/S

Completed

What the Body Does to Foliglurax in Healthy Volunteers (Foliglurax)

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women

Cytochrome P450 Interaction

United Kingdom, United States
H. Lundbeck A/S

Completed

Single Dose of Lu AF28996 to Healthy Young Men

Healthy

Netherlands
H. Lundbeck A/S

Completed

Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression

Major Depressive Disorder

Bulgaria, Estonia, Latvia
H. Lundbeck A/S

Completed

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Alzheimer Dementia (AD)

China
H. Lundbeck A/S

Completed

Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China (CHORAL)

Parkinson's Disease

China
H. Lundbeck A/S

Terminated

Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease

Alzheimer's Disease

United States
H. Lundbeck A/S

Completed

Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes

Drug Reactions

United Kingdom
H. Lundbeck A/S

Completed

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Major Depression Disorder

Germany, United States, Estonia, Finland, Poland
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder

Major Depressive Disorder

Finland, Germany, Serbia, Slovakia, Estonia
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

Major Depressive Disorder

Finland, Germany, Serbia, Slovakia
H. Lundbeck A/S

Completed

Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use

Alcohol Dependence

Germany
H. Lundbeck A/S

Withdrawn

Bioequivalence Study of Idalopirdine in Healthy Subjects

Bioequivalence

United Kingdom
H. Lundbeck A/S

Completed

Safety and Efficacy of Zicronapine in Patients With Schizophrenia

Schizophrenia

Czech Republic, Estonia, Finland, France, Poland
H. Lundbeck A/S

Completed

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Renal Impairment

Germany
H. Lundbeck A/S

Completed

Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

Schizophrenia

United States
H. Lundbeck A/S

Completed

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Irritability | Major Depressive Disorder

United States
H. Lundbeck A/S

Completed

Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 Entering the Body and Subsequently Elimination. The Study is a Drug-drug Interaction Study in Healthy Volunteers.

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-3)

Stroke

Spain, Australia, Austria, Estonia, France, Germany, Hong Kong, India, Korea, Republic of, Netherlands, Philippines, Poland, Singapore, Switzerland, Taiwan, Thailand, Vietnam
H. Lundbeck A/S

Completed

Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects

Healthy Men

France
H. Lundbeck A/S

Completed

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

Insomnia
H. Lundbeck A/S

Completed

Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women

Healthy Women

United Kingdom
H. Lundbeck A/S

Completed

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Alcohol Dependence

United Kingdom
H. Lundbeck A/S

Completed

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Healthy Men and Women

United Kingdom
H. Lundbeck A/S

Completed

Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects

Healthy Volunteers

France
H. Lundbeck A/S

Completed

Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia

Schizophrenia | Cognition

United States
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder

3

Subscribe